Andrew Callos

Andrew Callos

Corporate Officer/Principal at CYTOKINETICS, INCORPORATED

Net worth: 4 M $ as of 2026-05-30

57 year
Health Technology
Consumer Services

Profile

Andrew M.
Callos
is Chief Commercial Officer & Executive VP at Cytokinetics, Inc. since 2021.
Formerly, Mr. Callos was Vice President-US Cardiology & Metabolic Marketing at Pfizer Inc. and Assistant Vice President-Marketing at Wyeth Pharmaceuticals, Inc. Mr. Callos completed undergraduate education at Drexel University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 58,555 ( 0.05% ) 4 M $ 2026-05-30

Andrew Callos active positions

CompaniesPositionStart
CYTOKINETICS, INCORPORATED Corporate Officer/Principal 2021-02-28

Former positions of Andrew Callos

CompaniesPositionEnd
PFIZER INC. Corporate Officer/Principal -
Sales & Marketing -
See the detail of Andrew Callos's experience

Training of Andrew Callos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

17

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Health Technology

Health Technology

Consumer Services

Health Technology